Published in Laryngoscope on April 01, 2013
FDG-PET/CT pitfalls in oncological head and neck imaging. Insights Imaging (2014) 1.00
PET/MRI and PET/CT in follow-up of head and neck cancer patients. Eur J Nucl Med Mol Imaging (2014) 0.93
FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT. Eur Radiol (2015) 0.82
Surveillance radiologic imaging after treatment of oropharyngeal cancer: a review. World J Surg Oncol (2015) 0.78
The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature. Eur Arch Otorhinolaryngol (2015) 0.77
Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study. Nucl Med Commun (2017) 0.75
Optimized imaging of the midface and orbits. GMS Curr Top Otorhinolaryngol Head Neck Surg (2015) 0.75
Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol (2007) 6.65
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol (2014) 6.10
Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer. J Clin Oncol (2005) 3.01
The incidence of concha bullosa and its relationship to nasal septal deviation and paranasal sinus disease. AJNR Am J Neuroradiol (2004) 2.91
Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer. J Clin Oncol (2004) 2.27
Vascularized tissue to reduce fistula following salvage total laryngectomy: a systematic review. Laryngoscope (2014) 2.21
Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck (2011) 1.97
Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors. J Clin Oncol (2007) 1.95
Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg (2008) 1.68
International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers. J Nucl Med (2013) 1.63
Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage. Int J Radiat Oncol Biol Phys (2007) 1.57
Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen. J Urol (2003) 1.57
Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET. Blood (2011) 1.55
Transoral resection of short segment Zenker's diverticulum and cricopharyngeal myotomy: an alternative minimally invasive approach. Laryngoscope (2010) 1.49
Cancers of the oral cavity and oropharynx: FDG PET with contrast-enhanced CT in the posttreatment setting. Radiographics (2011) 1.47
Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology (2003) 1.42
Prognostic significance of microscopic and macroscopic extracapsular spread from metastatic tumor in the cervical lymph nodes. Oral Oncol (2002) 1.38
Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma. J Clin Oncol (2005) 1.38
The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg (2006) 1.35
Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigen. J Urol (2003) 1.31
Elective and therapeutic selective neck dissection. Oral Oncol (2005) 1.26
Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen. Semin Oncol (2003) 1.24
FDG-PET lymphoma demonstration project invitational workshop. Acad Radiol (2007) 1.20
Role of 3D CT in the evaluation of the temporal bone. Radiographics (2006) 1.19
Endoscopic stapling technique for the treatment of Zenker diverticulum vs standard open-neck technique: a direct comparison and charge analysis. Arch Otolaryngol Head Neck Surg (2002) 1.17
18F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: a first-in-human study of radiochemical safety, biokinetics, and radiation dosimetry. J Nucl Med (2013) 1.15
Prediction of myelotoxicity based on bone marrow radiation-absorbed dose: radioimmunotherapy studies using 90Y- and 177Lu-labeled J591 antibodies specific for prostate-specific membrane antigen. J Nucl Med (2005) 1.14
Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options. Head Neck (2011) 1.13
Granulocytic sarcoma of the temporal bone. AJNR Am J Neuroradiol (2002) 1.12
Grisel's syndrome in head and neck practice. Oral Oncol (2005) 1.11
Discrimination of benign and neoplastic mucosa with a high-resolution microendoscope (HRME) in head and neck cancer. Ann Surg Oncol (2012) 1.11
Prophylactic swallowing exercises in patients with head and neck cancer undergoing chemoradiation: a randomized trial. Arch Otolaryngol Head Neck Surg (2012) 1.11
Pharmacokinetics and biodistribution of 111In- and 177Lu-labeled J591 antibody specific for prostate-specific membrane antigen: prediction of 90Y-J591 radiation dosimetry based on 111In or 177Lu? J Nucl Med (2005) 1.10
Cutaneous squamous cell carcinoma of the head and neck. J Skin Cancer (2011) 1.09
Radioimmunotherapy of prostate cancer using 90Y- and 177Lu-labeled J591 monoclonal antibodies: effect of multiple treatments on myelotoxicity. Clin Cancer Res (2005) 1.08
The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer. Cancer (2009) 1.07
Zenker diverticulum. Otolaryngol Clin North Am (2013) 1.05
Proposal for a rational classification of neck dissections. Head Neck (2010) 1.04
Craniopharyngioma: a pathologic, clinical, and surgical review. Head Neck (2011) 1.04
Modern reconstruction techniques for oral and pharyngeal defects after tumor resection. Eur Arch Otorhinolaryngol (2007) 1.04
Correlation of positron emission tomography standard uptake value and pathologic specimen size in cancer of the head and neck. Int J Radiat Oncol Biol Phys (2008) 1.03
Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate. Head Neck (2014) 1.02
Transoral robotic assisted free flap reconstruction. Otolaryngol Head Neck Surg (2009) 1.02
A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: a systematic review. Laryngoscope (2014) 1.02
Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer. Cancer (2011) 1.01
Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol (2012) 1.00
Diagnosis and treatment of recurrent laryngeal cancer following initial nonsurgical therapy. Head Neck (2011) 0.99
A systematic review of head and neck cancer quality of life assessment instruments. Oral Oncol (2012) 0.99
Imaging the facial nerve: a contemporary review. Radiol Res Pract (2013) 0.99
The role of intraoperative rapid parathyroid hormone monitoring for predicting thyroidectomy-related hypocalcemia. Arch Otolaryngol Head Neck Surg (2004) 0.96
Vessel-depleted neck: techniques for achieving microvascular reconstruction. Head Neck (2008) 0.96
Interleukin-12 expression enhances vesicular stomatitis virus oncolytic therapy in murine squamous cell carcinoma. Laryngoscope (2007) 0.96
Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia. Head Neck (2012) 0.96
Current trends in initial management of oropharyngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol (2009) 0.96
Amyloidosis concurrently involving the sinonasal cavities and larynx. AJNR Am J Neuroradiol (2004) 0.95
Role of FDG PET/CT in staging of recurrent ovarian cancer. Radiographics (2011) 0.95
Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases. PLoS One (2012) 0.95
Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma. Cancer (2008) 0.94
Follicular adenoma in a juxtathyroidal thyroglossal duct cyst with papillary carcinoma in the adjacent thyroid gland. Am J Otolaryngol (2005) 0.93
FDG PET with contrast-enhanced CT: a critical imaging tool for laryngeal carcinoma. Radiographics (2010) 0.92
Palliative surgery for head and neck cancer with extensive skin involvement. Laryngoscope (2013) 0.92
Surgical anatomy of the recurrent laryngeal nerve revisited. Otolaryngol Head Neck Surg (2005) 0.92
Fusogenic vesicular stomatitis virus for the treatment of head and neck squamous carcinomas. Otolaryngol Head Neck Surg (2007) 0.92
Imaging the paranasal sinuses: where we are and where we are going. Anat Rec (Hoboken) (2008) 0.92
Role of the island deltopectoral flap in contemporary head and neck reconstruction. Ann Otol Rhinol Laryngol (2006) 0.90
Combined endoscope-assisted transclival clipping and endovascular stenting of a basilar trunk aneurysm: case report. Neurosurgery (2008) 0.90
Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials? Blood (2012) 0.89
Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference: a comorbidity model. Neuropharmacology (2011) 0.89
The utility of monoclonal antibodies in the imaging of prostate cancer. Semin Urol Oncol (2002) 0.89
Primary sphenoid sinus esthesioneuroblastoma. Am J Otolaryngol (2004) 0.88
Transoral robotic surgery using a carbon dioxide flexible laser for tumors of the upper aerodigestive tract. Laryngoscope (2008) 0.88
Multiple adult rhabdomyomas of the oropharynx, base of the tongue, and floor of the mouth: magnetic resonance findings. Arch Otolaryngol Head Neck Surg (2008) 0.88
Robotic surgery for oropharynx cancer: promise, challenges, and future directions. Curr Oncol Rep (2012) 0.87
Prevention and management of treatment-induced pharyngo-oesophageal stricture. Lancet Oncol (2013) 0.87
High-Resolution Optical Imaging of Benign and Malignant Mucosa in the Upper Aerodigestive Tract: An Atlas for Image-Guided Surgery. ISRN Minim Invasive Surg (2012) 0.87
Transoral laser surgery for supraglottic cancer. Head Neck (2008) 0.87
Combining FDG-PET/CT with laboratory data yields superior results for prediction of relapse in multiple myeloma. Eur J Haematol (2011) 0.87
(18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study. Leuk Lymphoma (2014) 0.87
KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinoma. Int J Cancer (2007) 0.86
Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT). Abdom Imaging (2011) 0.86
The utility of concurrent rhinoplasty and sinus surgery: a 2-team approach. Arch Facial Plast Surg (2006) 0.86
Transoral robotic surgery using an image guidance system. Laryngoscope (2008) 0.86
The optimized evaluation of diabetic foot infection by dual isotope SPECT/CT imaging protocol. J Foot Ankle Surg (2010) 0.86
Using CT to localize side and level of vocal cord paralysis. AJR Am J Roentgenol (2003) 0.86
Subcutaneous mandibulotomy: a new surgical access for large tumors of the parapharyngeal space. Laryngoscope (2003) 0.85
Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all? Head Neck (2006) 0.85
PET/CT evaluation of cervical cancer: spectrum of disease. Radiographics (2010) 0.85
Minimally invasive techniques for head and neck malignancies: current indications, outcomes and future directions. Eur Arch Otorhinolaryngol (2011) 0.85
CT and MR imaging findings associated with subacute thyroiditis. AJNR Am J Neuroradiol (2003) 0.85
The potential of FDG PET/CT for early diagnosis of cardiac device and prosthetic valve infection before morphologic damages ensue. Curr Cardiol Rep (2014) 0.85
Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiation. Oncol Rep (2011) 0.84